Pharmacologic Therapy of Lower Urinary Tract Dysfunction

Clinical Obstetrics and Gynecology

Volumn 47, Issue 1, 2004, Pages 83-92

  Nygaard, Ingrid E ^a   Kreder, Karl J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BETHANECHOL; BUMETANIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DESMOPRESSIN; DIAZEPAM; DICYCLOVERINE; DOXEPIN; DULOXETINE; ESTRADIOL RECEPTOR; ESTROGEN; HYOSCYAMINE; IMIPRAMINE; LEVOMELOXIFENE; LEVSINEX; MICROSPHERE; MUSCARINIC RECEPTOR; NOREPHEDRINE; OXYBUTYNIN; PHENOXYBENZAMINE; PHENYLPROPANOLAMINE; PLACEBO; PROPANTHELINE BROMIDE; PROSTAGLANDIN E2; QUATERNARY AMMONIUM DERIVATIVE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CARDIOTOXICITY; CATAPLEXY; CLINICAL TRIAL; DETRUSOR MUSCLE; DIZZINESS; DROWSINESS; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DYSPHAGIA; EDEMA; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPONATREMIA; INTRAOCULAR PRESSURE ABNORMALITY; MICTURITION DISORDER; NOCTURIA; NOCTURNAL ENURESIS; ORTHOSTATIC HYPOTENSION; REVIEW; STOMACH ULCER; STRESS INCONTINENCE; URETHRA; URGE INCONTINENCE; URINE OSMOLALITY; URODYNAMICS; VISUAL IMPAIRMENT; XEROSTOMIA; FEMALE; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE INCONTINENCE;

ESTROGENS; FEMALE; HUMANS; URINARY INCONTINENCE; URINATION DISORDERS; URODYNAMICS;

EID: 1842432122     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200403000-00011     Document Type: Review

References (38)

1. Wein AJ. Pharmacologic treatment of incontinence. J Am Geriatr Soc. 1990;38:317-325.
2. Griebling TL, Nygaard IE. The role of estrogen replacement therapy in the management of urinary incontinence and urinary tract infection in postmenopausal women. Endocrinol Metabol Clin North Am. 1997;26:347-360.
3. Fantl JA, Bump RC, Robinson D, et al. Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group. Obstet Gynecol. 1996;88:745-749.
4. Jackson S, Shepherd A, Brookes S, et al. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol. 1999;106:711-718.
5. Grady D, Brown JS, Vittinghoff E, et al. The HERS Research Group. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progesterone Replacement Study. Obstet Gynecol. 2001;97:116-120.
6. Goldstein SR, Neven P, Zhou L, et al. Raloxifene effect on frequency of surgery for pelvic floor relaxation. Obstet Gynecol. 2001;98:91-96.
7. Goldstein SR, Nanavati N. Adverse events that are associated with the selective estrogen receptor modulator levomeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol. 2002;187:521-527.
8. Wall LL. Diagnosis and management of urinary incontinence due to detrusor instability. Obs Gyn Surg. 1990;45(Supp 11):1s-47s.
9. Haeusler G, Letitch H, van Trotsenberg M, et al. Drug therapy of urinary urge incontinence: a systematic review. Obstet Gynecol. 2002;100:1003-1016.
10. Baigrie RJ, Kelleher JP, Fawcett DP, et al. Oxybutynin: is it safe? Br J Urol. 1988;62:319-322.
11. Zorzitto ML, Jewett MAS, Fernie GR, et al. Effectiveness of propantheline bromide in the treatment of geriatric patients with detrusor instability. Neurourol Urodyn. 1986;5:133-140.
12. Ouslander JG, Blaustein J, Connor A, et al. Habit training and oxybutynin for incontinence in nursing home patients: a placebo-controlled trial. J Am Geriatr Soc. 1988;36:40-46.
13. Kasabian NG, Vlachiotis JD, Lais A, et al. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia. J Urol. 1994;151:944-945.
14. Enzelsberger H, Helmer H, Kurz CH. Intravesical instillation of oxybutynin in women with idiopathic detrusor instability: a randomized trial. Br J Obstet Gynaecol. 1995;102:929-930.
15. Abrams P, Freeman R, Anderstrom C, et al. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol. 1998;81:801-810.
16. Van Kerrebroeck P, Kreder KJ, Jonas U. et al for the Tolterodine Study Group. Tolterodine once-daily: superior efficacy and tolerability in the treatment of overactive bladder. Urology. 2001;57:414-421.
17. Portera SG, Lipscomb GH. Pharmacologic therapy for urinary incontinence and voiding dysfunction. Clin Obstet Gynecol. 1998;41:691-701.
18. Appell RA, Sand P, Dmochowski R, et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT study. Mayo Clin Proc. 2001;76:358-363.
19. Fischer-Rasmussen W. Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study. Scand J Urol Nephrol Suppl. 1984;87:35-47.
20. Ouslander JG, Sier HC. Drug therapy for geriatric urinary incontinence. Clin Geriatr Med. 1986;2:789-807.
21. Lepor H, Theune C. Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms. J Urol. 1995;154:116-118.
22. Sher PK, Reinberg Y. Successful treatment of giggle incontinence with methylphenidate. J Urol. 1996;156:656-658.
23. Aitchison M, Carter R, Paterson P, et al. Is the treatment of urgency incontinence a placebo response? Results of a five-year follow-up. Br J Urol 1989;64:478-480.
24. Kelleher CJ, Cardozo LD, Khullar V, et al. A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol. 1997;104:988-993.
25. Lawrence M, Guar DR, Benson SR, et al. Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis. Pharmacotherapy. 2000;20:470-475.
26. Collste C, Lindskog M. Phenylpropanolamine in the treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients. Urology. 1987;30:398-403.
27. Ek A, Andersson KE, Gullberg B, et al. The effects of long-term treatment with norephedrine on stress incontinence and urethral closure pressure profile. Scand J Urol Nephrol. 1978;12:105-110.
28. Ahlström K, Sandahl B, Sjöberg B, et al. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence. Gynecol Obstet Invest. 1990;30:37-43.
29. Ek A, Andersson KE, Gullberg B, et al. Effects of oestradiol and combined norephedrine and oestradiol treatment on female stress incontinence. Zentralbl Gynakol. 1980;102:839-844.
30. Beisland HO, Fossberg E, Moer A, et al. Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation. Urol Int. 1984;39:211-216.
31. Norton PA, Zinner NR, Talcin I, et al. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol. 2002;187:40-48.
32. Janknegt RA, Zweers HM, DeLaere KP, et al. Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: a double-blind, randomized, multicenter study. J Urol. 1997;157:513-517.
33. Valiquette G, Herbert J, Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind cross-over trial. Arch Neurol. 1996;53:1270-1275.
34. Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987;316:363-369.
35. Hunsballe JM, Rittig S, Pedersen EB, et al. Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria. J Urol. 1997;158:830-836.
36. Pedersen PA, Johansen PB. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol. 1988;62:145-147.
37. Tammela T. Prevention of prolonged voiding problems after unexpected postoperative urinary retention: comparison of phenoxybenzamine and carbachol. J Urol. 1986;136:1254-1257.
38. Stanton SL, Cardozo LD, Kerr-Wilson R. Treatment of delayed onset of spontaneous voiding after surgery for incontinence. Urology. 1979;13:494-496.